Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors

The gastrointestinal hormone ghrelin reduces energy expenditure and stimulates food intake. Ghrelin analogs are a possible treatment against cancer anorexia-cachexia syndrome (CACS). This study aimed to investigate whether oral treatment with the non-peptidergic ghrelin receptor agonist HM01 counter...

Descripción completa

Detalles Bibliográficos
Autores principales: Villars, Fabienne O., Pietra, Claudio, Giuliano, Claudio, Lutz, Thomas A., Riediger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454899/
https://www.ncbi.nlm.nih.gov/pubmed/28475119
http://dx.doi.org/10.3390/ijms18050986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454899/
https://www.ncbi.nlm.nih.gov/pubmed/28475119
http://dx.doi.org/10.3390/ijms18050986

Ejemplares similares